Joincare Pharmaceutical Group Industry Co Ltd
Joincare Pharmaceutical Group Industry Co.,Ltd. engages in the research, development, production, and sale of pharmaceuticals and health care products in China. The company offers chemical pharmaceuticals for respiratory, gastroenterology, assisted reproduction, psychiatry, and anti-infection; chemical APIs and intermediates for drugs for humans and veterinary drugs; and traditional Chinese medic… Read more
Joincare Pharmaceutical Group Industry Co Ltd (600380) - Total Liabilities
Latest total liabilities as of September 2025: CN¥11.93 Billion CNY
Based on the latest financial reports, Joincare Pharmaceutical Group Industry Co Ltd (600380) has total liabilities worth CN¥11.93 Billion CNY as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Joincare Pharmaceutical Group Industry Co Ltd - Total Liabilities Trend (1997–2024)
This chart illustrates how Joincare Pharmaceutical Group Industry Co Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Joincare Pharmaceutical Group Industry Co Ltd Competitors by Total Liabilities
The table below lists competitors of Joincare Pharmaceutical Group Industry Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Kumho Petro Chemical
KO:011780
|
Korea | ₩2.19 Trillion |
|
China Conch Venture Holdings Limited
PINK:CCVTF
|
USA | $33.40 Billion |
|
Liberty Latin America Ltd Class C
NASDAQ:LILAK
|
USA | $10.89 Billion |
|
Virbac SA
PINK:VRBCF
|
USA | $750.28 Million |
|
Pci-Suntek Technology Co Ltd
SHG:600728
|
China | CN¥7.41 Billion |
|
Beijing Xinleineng Technology Co Ltd
SHE:300593
|
China | CN¥1.81 Billion |
|
PCCOF
PINK:PCCOF
|
USA | $233.44 Billion |
|
Atlas Energy Solutions Inc.
NYSE:AESI
|
USA | $1.02 Billion |
Liability Composition Analysis (1997–2024)
This chart breaks down Joincare Pharmaceutical Group Industry Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.63 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.80 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.33 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Joincare Pharmaceutical Group Industry Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Joincare Pharmaceutical Group Industry Co Ltd (1997–2024)
The table below shows the annual total liabilities of Joincare Pharmaceutical Group Industry Co Ltd from 1997 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | CN¥12.32 Billion | -10.21% |
| 2023-12-31 | CN¥13.72 Billion | +0.07% |
| 2022-12-31 | CN¥13.71 Billion | +25.49% |
| 2021-12-31 | CN¥10.92 Billion | +22.47% |
| 2020-12-31 | CN¥8.92 Billion | +10.76% |
| 2019-12-31 | CN¥8.05 Billion | -7.31% |
| 2018-12-31 | CN¥8.69 Billion | +1.11% |
| 2017-12-31 | CN¥8.59 Billion | +27.56% |
| 2016-12-31 | CN¥6.74 Billion | +3.83% |
| 2015-12-31 | CN¥6.49 Billion | +17.06% |
| 2014-12-31 | CN¥5.54 Billion | +17.41% |
| 2013-12-31 | CN¥4.72 Billion | +13.39% |
| 2012-12-31 | CN¥4.16 Billion | +24.11% |
| 2011-12-31 | CN¥3.35 Billion | +87.33% |
| 2010-12-31 | CN¥1.79 Billion | +2.67% |
| 2009-12-31 | CN¥1.74 Billion | -10.99% |
| 2008-12-31 | CN¥1.96 Billion | +0.81% |
| 2007-12-31 | CN¥1.94 Billion | +4.31% |
| 2006-12-31 | CN¥1.86 Billion | +36.66% |
| 2005-12-31 | CN¥1.36 Billion | -5.37% |
| 2004-12-31 | CN¥1.44 Billion | +4.17% |
| 2003-12-31 | CN¥1.38 Billion | +170.51% |
| 2002-12-31 | CN¥511.40 Million | +47.72% |
| 2001-12-31 | CN¥346.20 Million | -31.01% |
| 2000-12-31 | CN¥501.77 Million | +1.96% |
| 1999-12-31 | CN¥492.14 Million | +8.74% |
| 1998-12-31 | CN¥452.60 Million | +33.54% |
| 1997-12-31 | CN¥338.94 Million | -- |